Feedback / Questions
Ryjunea (atropine sulfate) - Sydnexis
https://www.businesswire.com/news/home/20250605515551/en/Sydnexis-Announces-European-Commission-Approval-of-SYD-101-the-First-and-Only-Pharmaceutical-Treatment-for-Slowing-the-Progression-of-Pediatric-Myopia
Jun 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next